Profile picture

Professor Hugo Katus

University Hospital Heidelberg, Heidelberg (Germany)
Membership: FESC Member
Follow
Biography
Prof. Hugo A Katus is Prof. of Intern. Med. He was until Oct 2020 Dir. of the Dep. of Intern. Med. III and Head of Intern. Med. at the University of Heidelberg in Germany. He was also Head of Cardiology at two affiliated hospitals in the area. Prof. Katus is now emeritus and holds a position as senior prof. at the University and Hospital in Heidelberg. Prof. Katus is co-founder of the Acad. of German Cardiac Soc. and has served as President of German Cardiac Societey. Prof Katus invented the cardiac troponin T assay, for which he held a patent jointly with Roche Diagnostics. This invention changed practice of cardiology. In addition to his research interest in cardiac biomarkers he focused on molecular and genetic causes of cardiomyopathies and promoted in the translation of novel diagnostic and therapeutic strategies in heart failure. He is Co-Founder of Inocard and AaviGen, two start up companies developing gene therepies against heart failure
Logo ESC

Contributor content

Prognosis post-acute coronary syndromes
Session
Prognosis post-acute coronary syndromes
31 August 2025
Chronic coronary syndromes: invasive and non-invasive diagnostics (2)
Session
Chronic coronary syndromes: invasive and non-invasive diagnostics (2)
30 August 2025
HOT LINE 12
Session
HOT LINE 12
2 September 2024
High-sensitivity cardiac troponin assays: integrating evidence from clinical trials and implementation studies
Session
High-sensitivity cardiac troponin assays: integrating evidence from clinical trials and implementation studies
31 August 2024
ESC Paul Hugenholtz Lecture in Innovation
Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023
ESC Paul Hugenholtz Lecture in Innovation
Session
ESC Paul Hugenholtz Lecture in Innovation
26 August 2022
Management of risk factors in the elderly
Session
Management of risk factors in the elderly
30 August 2021
Precision medicine: novel biomarkers for patient risk stratification
Session
Precision medicine: novel biomarkers for patient risk stratification
3 September 2019
Meet the trialist - HiSTORIC
Session
Meet the trialist - HiSTORIC
2 September 2019
Data Analysis
Session
Data Analysis
2 September 2019

ESC 365 is supported by